| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1333231-43-8 | N-[(1S)-1-[[[(1S)-1-(Hydroxymethyl)-2-(2-oxo-3-pyrrolidinyl)ethyl]amino]carbonyl]-3-methylbutyl]carbamic acid phenylmethyl ester | C21H31N3O5 |
| 1333317-99-9 | Poly[[(2,4,6-trimethylphenyl)imino][1,1'-biphenyl]-4,4'-diyl] | (C21H19N)n |
| 1333323-17-3 | 10-Deacetylyunnanxane | C29H44O8 |
| 1333377-65-3 | 3-(1H-Indazol-5-yl)-N-propylimidazo[1,2-b]pyridazin-6-amine | C16H16N6 |
| 1333390-56-9 | Regorafenib Urea Impurity | C14H9ClF4N2O2 |
| 1333472-28-8 | Terbutaline impurity 13 | C10H11BrO3 |
| 1333995-14-4 | Aprepitant Impurity 5 HCl | C20H18F7NO2 .HCl |
| 1333998-21-2 | Des-1,2,4-triazol-3-one-5-methyl (2R,3R,2-(S))-Aprepitant Hydrochloride | C20H19ClF7NO2 |
| 1333998-27-8 | Fosaprepitant Morpholine Hydrochloride | C20H19ClF7NO2 |
| 1334172-76-7 | (3aS,4S,6aR)-N-(23-Amino-3,6,9,12,15,18,21-heptaoxatricos-1-yl)hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide | C26H50N4O9S |
| 1334177-86-4 | 1-Maleimido-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-aza-hentriacontan-31-oic acid | C26H44N2O13 |
| 1334179-85-9 | 2-[4-[(Bis[(1-tert-butyl-1H-1,2,3-triazol-4-yl)methyl]amino)methyl]-1H-1,2,3-triazol-1-yl]acetic acid | C19H30N10O2 |
| 1334237-71-6 | Velcalcetide hydrochloride | C38H73N21O10S2.x(HCl) |
| 1334294-43-7 | 6-Chloro-4-(4-morpholinylmethyl)-2-pyridinamine | C10H14ClN3O |
| 1334298-90-6 | Itacitinib | C26H23F4N9O |
| 1334298-96-2 | 1-[1-[2-Fluoro-3-(trifluoromethyl)benzoyl]-4-piperidinyl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile | C27H24F4N8O |
| 1334302-63-4 | Hexanedioic acid, compd. with 1-[1-[[3-fluoro-2-(trifluoromethyl)-4-pyridinyl]carbonyl]-4-piperidinyl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile (1:1) | C26H23F4N9O.C6H10O4 |
| 1334309-44-2 | 3'-Geranyl-3-prenyl-2',4',5,7-tetrahydroxyflavone | C30H34O6 |
| 1334320-67-0 | 2-Deoxy-2-(chloroacetamido)-D-glucopyranose | C8H14ClNO6 |
| 1334320-73-8 | 2-Deoxy-2-(2-mercaptoacetamido)glucopyranose | C8H15NO6S |
| 1334321-39-9 | (alphaR)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.1(3,7)]decane-1-acetic acid | C17H27NO5 |
| 1334493-07-0 | 4-[[(4-Cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-2-hydroxybenzoic acid | C29H27F5N2O6S |
| 1334497-06-1 | Chloro(crotyl)[di-tert-butyl(4-dimethylaminophenyl)phosphine]palladium(II) | C20H35ClNPPd |
| 1334499-86-3 | 5-Fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid ethyl ester | C10H8FIN2O2 |
| 1334499-90-9 | 5,7-Difluoro-3-iodo-1H-indole-2-carboxylic acid ethyl ester | C11H8F2INO2 |
| 1334509-86-2 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-methyl-L-tryptophan | C27H24N2O4 |
| 1334509-91-9 | N-(tert-Butoxycarbonyl)-3-[4-(tert-butoxycarbonyl)piperazin-1-yl]-L-alanine | C17H31N3O6 |
| 1334513-02-8 | N-[(S)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester | C18H17F5NO5P |
| 1334513-10-8 | N-[[P(S),2'R]-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-cytidylyl]-L-alanine 1-methylethyl ester | C22H30FN4O8P |
| 1334541-27-3 | 4-Iodo-1-phenyl-1H-imidazole | C9H7IN2 |
| 1334546-77-8 | 3-Amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-2-pyridinecarboxamide | C12H13F6N3O3 |
| 1334547-47-5 | 5,5',5''-[1,3,5-Benzenetriyltris(1H-1,2,3-triazole-4,1-diyl)]tris-1,3-benzenedicarboxylic acid | C36H21N9O12 |
| 1334547-76-0 | Chloro(2-{bis[3,5-bis(trifluoromethyl)phenyl]phosphino}-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl)gold(I) | C39H37AuClF12O2P |
| 1334719-95-7 | 6-Chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]-1-piperidinyl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide | C29H28ClF3N4O2 |
| 1334782-79-4 | 2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-[2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone | C29H32N6OS |
| 1334890-93-5 | (1,10-Phenanthroline)(trifluoromethyl)(triphenylphosphine)copper(I) | C31H23CuF3N2P |
| 1335054-04-0 | Ethyl 6-bromo-4-chloronicotinate | C8H7BrClNO2 |
| 1335054-80-2 | 2-Bromo[1,2,4]triazolo[1,5-a]pyrimidine | C5H3BrN4 |
| 1335056-34-2 | 4-Bromo-3-pyridinemethanamine hydrochloride | C6H7BrN2.HCl |
| 1335057-22-1 | 5-Bromo-6-chloro-3-nitro-2-pyridinamine | C5H3BrClN3O2 |
| 1335095-08-3 | 3,4-Dihydro-1-hydroxy-1H-2,1-benzoxaborin-7-amine | C8H10BNO2 |
| 1335110-44-5 | Rosuvastatin EP impurity H | C23H31FN3O6S- |
| 1335116-38-5 | (3S)-1-(4-Piperidinyl)-3-pyrrolidinol | C9H18N2O |
| 1335117-26-4 | (3R)-1-(4-Piperidinyl)-3-pyrrolidinol | C9H18N2O |
| 1335202-59-9 | 2-[3-Cyano-4-(1-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid | C16H16N2O3S |
| 1335202-60-2 | 2-Isobutoxy-5-(4-methylthiazol-2-yl)benzonitrile | C15H16N2OS |
| 1335210-23-5 | 1-(2,2-Dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2,5-pyridinedicarboxylic acid 2-methyl ester | C13H17NO8 |
| 1335210-24-6 | Cabotegravir Intermediate | C13H14N2O6 |
| 1335210-26-8 | Methyl 2-(((2,2-dimethoxyethyl)amino)methylene)-4-methoxy-3-oxobutanoate | C11H19NO6 |
| 1335210-28-0 | 1-(2,2-Dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2,5-pyridinedicarboxylic acid 2-ethyl 5-methyl ester | C15H21NO8 |